Icu Medical (ICUI) | Financial Analysis & Statements
Icu Medical Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
540.7M
Gross Profit
203.0M
37.54%
Operating Income
26.1M
4.82%
Net Income
-15.7M
-2.91%
Balance Sheet Metrics
Total Assets
4.1B
Total Liabilities
1.9B
Shareholders Equity
2.1B
Debt to Equity
0.91
Cash Flow Metrics
Operating Cash Flow
67.3M
Free Cash Flow
34.2M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Icu Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.2B | 2.4B | 2.3B | 2.3B | 1.3B |
| Cost of Goods Sold | 1.4B | 1.6B | 1.5B | 1.6B | 824.8M |
| Gross Profit | 822.0M | 824.8M | 739.9M | 697.8M | 491.5M |
| Gross Margin % | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% |
| Operating Expenses | |||||
| Research & Development | 87.5M | 88.6M | 85.3M | 93.0M | 47.5M |
| Selling, General & Administrative | 625.2M | 638.8M | 606.7M | 608.3M | 302.6M |
| Other Operating Expenses | - | - | - | - | 127.0K |
| Total Operating Expenses | 712.7M | 727.4M | 692.0M | 701.3M | 350.2M |
| Operating Income | 109.3M | 97.4M | 47.8M | -3.6M | 141.3M |
| Operating Margin % | 4.9% | 4.1% | 2.1% | -0.2% | 10.7% |
| Non-Operating Items | |||||
| Interest Income | 10.3M | 10.8M | 7.5M | 4.4M | 2.8M |
| Interest Expense | 93.3M | 106.5M | 102.7M | 70.8M | 858.0K |
| Other Non-Operating Income | -21.9M | -67.7M | -30.9M | -44.5M | -20.1M |
| Pre-tax Income | 4.4M | -66.0M | -78.3M | -114.4M | 123.2M |
| Income Tax | 2.4M | 51.7M | -48.6M | -40.1M | 20.1M |
| Effective Tax Rate % | 55.9% | 0.0% | 0.0% | 0.0% | 16.3% |
| Net Income | 732.0K | -117.7M | -29.7M | -74.3M | 103.1M |
| Net Margin % | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% |
| Key Metrics | |||||
| EBITDA | 320.7M | 325.9M | 284.3M | 239.2M | 234.4M |
| EPS (Basic) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 |
| EPS (Diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| Basic Shares Outstanding | 24640000 | 24388000 | 24091000 | 23868000 | 21206000 |
| Diluted Shares Outstanding | 24640000 | 24388000 | 24091000 | 23868000 | 21206000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Icu Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 308.0M | 308.6M | 254.2M | 208.8M | 552.8M |
| Short-term Investments | - | 0 | 501.0K | 4.2M | 14.4M |
| Accounts Receivable | 180.5M | 182.8M | 161.6M | 221.7M | 105.9M |
| Inventory | 615.9M | 584.7M | 709.4M | 696.0M | 290.2M |
| Other Current Assets | 20.5M | 4.7M | 3.7M | 3.5M | 2.2M |
| Total Current Assets | 1.2B | 1.4B | 1.2B | 1.2B | 1.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 492.8M | 454.3M | 556.1M | 527.2M | 443.7M |
| Goodwill | 3.6B | 3.6B | 3.8B | 3.9B | 275.2M |
| Intangible Assets | 633.6M | 740.8M | 870.6M | 982.8M | 188.3M |
| Long-term Investments | 3.8M | 5.7M | 4.9M | 26.8M | 0 |
| Other Non-Current Assets | 79.4M | 80.3M | 120.6M | 104.4M | 100.4M |
| Total Non-Current Assets | 2.9B | 2.8B | 3.2B | 3.3B | 850.9M |
| Total Assets | 4.1B | 4.2B | 4.4B | 4.5B | 1.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 154.4M | 148.0M | 150.0M | 215.9M | 81.1M |
| Short-term Debt | 18.8M | 66.7M | 71.2M | 47.9M | 9.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | 40.3M | 7.5M | 1.8M | - |
| Total Current Liabilities | 498.9M | 556.2M | 481.8M | 494.6M | 200.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.3B | 1.6B | 1.6B | 1.7B | 36.0M |
| Deferred Tax Liabilities | 37.8M | 48.8M | 55.9M | 126.0M | 1.5M |
| Other Non-Current Liabilities | 41.9M | 10.1M | 33.9M | 54.4M | 4.3M |
| Total Non-Current Liabilities | 1.4B | 1.7B | 1.8B | 1.9B | 63.9M |
| Total Liabilities | 1.9B | 2.2B | 2.3B | 2.4B | 264.7M |
| Equity | |||||
| Common Stock | 2.5M | 2.5M | 2.4M | 2.4M | 2.1M |
| Retained Earnings | 690.9M | 690.2M | 807.8M | 837.5M | 911.8M |
| Treasury Stock | 22.0K | 92.0K | 262.0K | 243.0K | 27.0K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.1B | 2.0B | 2.1B | 2.1B | 1.6B |
| Key Metrics | |||||
| Total Debt | 1.3B | 1.6B | 1.7B | 1.7B | 45.0M |
| Working Capital | 691.7M | 885.8M | 739.4M | 740.6M | 829.0M |
Balance Sheet Composition
Icu Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 732.0K | -117.7M | -29.7M | -74.3M | 103.1M |
| Depreciation & Amortization | 200.7M | 219.5M | 228.8M | 235.2M | 89.7M |
| Stock-Based Compensation | 55.8M | 46.9M | 40.6M | 36.0M | 27.3M |
| Working Capital Changes | -42.1M | -14.4M | -132.8M | -270.8M | 16.8M |
| Operating Cash Flow | 263.0M | 182.7M | 144.5M | -37.1M | 266.4M |
| Investing Activities | |||||
| Capital Expenditures | -88.0M | -79.4M | -83.9M | -90.3M | -68.5M |
| Acquisitions | 211.2M | 0 | 0 | -1.8B | -14.5M |
| Investment Purchases | - | 0 | 0 | -3.4M | -13.3M |
| Investment Sales | 0 | 500.0K | 4.2M | 36.4M | 18.0M |
| Investing Cash Flow | 131.2M | -78.1M | -78.2M | -1.9B | -78.1M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 313.0K | 0 | 0 | 1.7B | 0 |
| Debt Repayment | -304.8M | -52.1M | -30.7M | -23.1M | -607.0K |
| Financing Cash Flow | -317.6M | -66.7M | -40.0M | 1.6B | -26.2M |
| Free Cash Flow | 82.8M | 113.8M | 72.5M | -161.5M | 186.4M |
| Net Change in Cash | 76.6M | 37.9M | 26.3M | -309.3M | 162.1M |
Cash Flow Trend
Icu Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
4,245.33
Forward P/E
13.86
Price to Book
1.48
Price to Sales
1.43
PEG Ratio
-124.79
Profitability Ratios
Profit Margin
0.03%
Operating Margin
4.82%
Return on Equity
0.04%
Return on Assets
1.66%
Financial Health
Current Ratio
2.39
Debt to Equity
63.48
Beta
0.85
Per Share Data
EPS (TTM)
$0.03
Book Value per Share
$86.03
Revenue per Share
$90.55
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ICUI | 3.1B | 4,245.33 | 1.48 | 0.04% | 0.03% | 63.48 |
| Intuitive Surgical | 170.1B | 54.97 | 8.99 | 16.69% | 28.38% | 0.95 |
| Becton, Dickinson | 56.1B | 25.40 | 1.75 | 6.96% | 8.01% | 77.28 |
| Baxter International | 9.4B | 86.31 | 1.54 | -13.71% | -8.51% | 160.28 |
| AptarGroup | 8.0B | 21.10 | 2.99 | 15.10% | 10.40% | 57.10 |
| Repligen | 7.5B | 154.30 | 3.55 | 2.40% | 6.62% | 32.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.






